Alr Technologies Sg LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
OTC.Pink
ALR Technologies reports significant net losses and substantial doubt regarding its ability to continue as a going concern for the 2025 fiscal year.
OTC.Pink
ALR Technologies SG Ltd. files an amendment to its 20-F annual report to correct the date of the Independent Registered Public Accounting Firm's report.
OTC.Pink
ALR Technologies SG Ltd. reports recurring losses and raises substantial doubt about its ability to continue as a going concern, despite efforts to develop and commercialize its Diabetes Solution and GluCurve products.
OTC.Pink
ALR Technologies SG Ltd. amends its 20-F report to address SEC comments, with no changes to the original financial statements.
OTC.Pink
ALR Technologies SG Ltd. reports recurring losses and uncertainties about raising additional funding, raising substantial doubt about its ability to continue as a going concern.